TrialJournal of clinical pharmacology2018

A Randomized, Single-Center, Double-Blind, Placebo-Controlled Multiple-Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Imarikiren in Healthy Adult Nonelderly and Elderly Male Subjects.

Kumi Matsuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.